1. Home
  2. ALBT vs BREA Comparison

ALBT vs BREA Comparison

Compare ALBT & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALBT
  • BREA
  • Stock Information
  • Founded
  • ALBT 2014
  • BREA 2022
  • Country
  • ALBT United States
  • BREA Ireland
  • Employees
  • ALBT N/A
  • BREA N/A
  • Industry
  • ALBT Biotechnology: Biological Products (No Diagnostic Substances)
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • ALBT Health Care
  • BREA Consumer Discretionary
  • Exchange
  • ALBT Nasdaq
  • BREA Nasdaq
  • Market Cap
  • ALBT 5.7M
  • BREA 13.6M
  • IPO Year
  • ALBT N/A
  • BREA 2023
  • Fundamental
  • Price
  • ALBT $2.57
  • BREA $6.58
  • Analyst Decision
  • ALBT
  • BREA
  • Analyst Count
  • ALBT 0
  • BREA 0
  • Target Price
  • ALBT N/A
  • BREA N/A
  • AVG Volume (30 Days)
  • ALBT 104.6K
  • BREA 21.0K
  • Earning Date
  • ALBT 08-18-2025
  • BREA 01-01-0001
  • Dividend Yield
  • ALBT N/A
  • BREA N/A
  • EPS Growth
  • ALBT N/A
  • BREA N/A
  • EPS
  • ALBT N/A
  • BREA N/A
  • Revenue
  • ALBT $807,235.00
  • BREA $2,988,009.00
  • Revenue This Year
  • ALBT N/A
  • BREA N/A
  • Revenue Next Year
  • ALBT N/A
  • BREA N/A
  • P/E Ratio
  • ALBT N/A
  • BREA N/A
  • Revenue Growth
  • ALBT N/A
  • BREA 151.51
  • 52 Week Low
  • ALBT $2.11
  • BREA $5.00
  • 52 Week High
  • ALBT $12.60
  • BREA $19.50
  • Technical
  • Relative Strength Index (RSI)
  • ALBT 37.26
  • BREA 45.35
  • Support Level
  • ALBT $2.52
  • BREA $6.06
  • Resistance Level
  • ALBT $2.74
  • BREA $8.59
  • Average True Range (ATR)
  • ALBT 0.28
  • BREA 0.72
  • MACD
  • ALBT -0.01
  • BREA -0.09
  • Stochastic Oscillator
  • ALBT 5.15
  • BREA 25.14

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: